Biotech Values

[DewDiligence]

Here’s the relevant exchange on the timing of the Copaxone patent trial (from the link in #msg-56214273):

David Amssellem (Piper Jaffray): Just coming back to that Copaxone litigation, just so I'm clear, is it your expectation that the trial date will be sometime in 2012, and given the protracted process is it your view that the FDA will necessarily have any sense of urgency in terms of reviewing the filings from Momenta and Mylan?

Bill Marth: I think to say that the trial is in 2012, that is not unreasonable at all. That would be fine.

Fine indeed. LOL